1 completed, 1 recruiting. 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Asthma (Part 1): new trials by email Literature Review of Asthma (Part 1) trials Research Report on Asthma (Part 1)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| APP-based Medical Device for Education and Training of Inhalation Technique App-based education and training of inhalation technique - Asthma (Part 1), COPD | Not applicable | Recruiting | Karolinska Institutet | 80 | 2025-06-01 | 2026-08-07 |
| Two-part Safety, Tolerability, Pharmacodynamic and -Kinetic Study of Inhaled AZD8871 in Asthmatic and COPD Subjects Dose 1, AZD8871 50 μg (Part 1), Dose 2, AZD8871 100 μg (Part 1), Dose 3, AZD8871 300 μg (Part 1) - Asthma (Part 1), COPD (Part 2) | Phase 1 | Completed | AstraZeneca | 134 | 2015-10-01 | 2018-11-08 |
Asthma (2) · Pulmonary Disease, Chronic Obstructive (2)
Bronchial Diseases (2) · Chronic Disease (2) · Disease Attributes (2) · Hypersensitivity (2) · Hypersensitivity, Immediate (2) · Immune System Diseases (2) · Lung Diseases (2) · Lung Diseases, Obstructive (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Respiratory Hypersensitivity (2) · Respiratory Tract Diseases (2)
AZD-8871 (1) · Tiotropium Bromide (1) · indacaterol (1)
AstraZeneca (1) · Karolinska Institutet (1)
Sweden (1) · United Kingdom (1)
Dave Singh, Prof. (1) · Muna Albayaty, MBChB, MSc,MFPM (1)
2015 (1)